Dalfampridine Real World Utilization and Efficacy Assessment (P7.244)
Sylvia Klineova(Icahn School of Medicine at Mount Sinai), Stephen Krieger(Icahn School of Medicine at Mount Sinai), Christine Hannigan(New York Audio Productions (United States)), Fred Lublin(Icahn School of Medicine at Mount Sinai), Colleen Farrell(University of Utah), Joshua Friedman(Icahn School of Medicine at Mount Sinai)
Cited by 1
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k